Livderm

June was Vitiligo Awareness Month—a time to spotlight the unique challenges vitiligo presents in skin of color.

For patients with darker skin tones, the higher contrast between depigmented patches and surrounding skin creates distinct clinical and psychosocial challenges.

In today's blog, we explore:
🔹 The unique presentation of vitiligo in skin of color
🔹 Tailored treatment strategies
🔹 The importance of psychosocial support
🔹 How clinicians can provide culturally sensitive care

🔗 Read the full blog now: https://go.livderm.org/3R9Lutb

As we recognize World Vitiligo Day and celebrate the South Beach Symposium (SBS) 25th Anniversary, we're proud to have spent the last quarter-century helping dermatology professionals stay current with the latest clinical research, emerging therapies, and best practices.

🎁 To celebrate this milestone, we're giving away one complimentary registration to SBS 2027!

How to enter:
✅ Complete the entry form between June 25–30, 2026
✅ One winner will be selected at random and notified after the giveaway closes

🔗 Enter now: https://go.livderm.org/4wgiFKB

P.S. Keep an eye on your inbox—we'll be announcing the winner soon!

A new era in sun protection is here. ☀️

The FDA just approved bemotrizinol—the first new sunscreen active ingredient in nearly 30 years.

Why is the dermatology community so excited? Read our latest blog to learn what makes bemotrizinol a game-changer and what it means for the future of skin health.

🔗 https://go.livderm.org/4elrb4O

☀️ Bemotrizinol is now officially available in the U.S., and it's a game-changer for sun protection.

Why it matters:
🔹 Protects against both UVA and UVB rays
🔹 No white residue like mineral sunscreens
🔹 Low skin absorption and recognized as safe for adults and children 6 months and older

Used safely in Europe and worldwide for years, bemotrizinol was fast-tracked under the CARES Act and approved in under 7 months.

This marks a major step forward in sunscreen innovation, consumer choice, and skin cancer prevention.

🔗 Read the full story: https://go.livderm.org/4a0Kn5q